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Porcine reproductive and respiratory syndrome virus (PRRSV) infections cause
significant economic losses to swine producers every year. Aerosols containing
infectious PRRSV are an important route of transmission, and proper treatment of air
could mitigate the airborne spread of the virus within and between barns. Previous
bioaerosol studies focused on the microbiology of PRRSV aerosols; thus, the current
study addressed the engineering aspects of virus aerosolization and collection. Specific
objectives were to (1) build and test a virus aerosolization system, (2) achieve a uniform
and repeatable aerosol generation and collection throughout all replicates, (3) identify
and minimize sources of variation, and (4) verify that the collection system (impingers)
performed similarly. The system for virus aerosolization was built and tested (Obj. 1).
The uniform airflow distribution was confirmed using a physical tracer (<12% relative
standard deviation) for all treatments and sound engineering control of flow rates (Obj.
2). Theoretical uncertainty analyses and mass balance calculations showed <3% loss of
air mass flow rate between the inlet and outlet (Obj. 3). A comparison of TCID50 values
among impinger fluids showed no statistical difference between any two of the three
trials (p-value = 0.148, 0.357, 0.846) (Obj. 4). These results showed that the readiness
of the system for research on virus aerosolization and treatment (e.g., by ultraviolet light),
as well as its potential use for research on other types of airborne pathogens and their
mitigation on a laboratory scale.
Keywords: airborne pathogens, animal production, infectious animal disease, livestock health, mass balance,
swine diseases, viral aerosol, virus isolation
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INTRODUCTION
Porcine reproductive and respiratory syndrome (PRRS) is one
of the most economically impactful diseases that need to be
mitigated to ensure animal production security. The annual cost
of PRRS to producers was estimated to be $560 million estimated
in 2005 (Neumann et al., 2005), $664 million in 2012 (Holtkamp
et al., 2013), and $580 million in 2016 (Miller, 2017). The disease
is caused by a single-stranded RNA virus (PRRSV), initially
described by Terpstra et al. (1991) and Wensvoort et al. (1991).
Air and aerosols are an important route of transmission
for some infectious diseases, e.g., foot-and-mouth disease virus
(FMDV) (Donaldson and Alexandersen, 2002) and influenza
virus (Herfst et al., 2012). PRRSV can be transmitted via indirect
contact (such as aerosol and fomites) or direct contact, but it
likewise is found in aerosols generated by infected pigs and reach
susceptible pigs meters or kilometers away (Torremorell et al.,
1997; Wills et al., 1997; Lager and Mengeling, 2000; Otake et al.,
2002; Dee et al., 2005; Arruda et al., 2019). Indeed, research
suggested that aerosols of infectious PRRSV can travel up to
∼9 km (Dee et al., 2009; Otake et al., 2010). The meteorological
conditions that favored long-distance transmission of airborne
virus included low temperature, moderate levels of relative
humidity, rising barometric pressure, low wind speed, and low
sunlight intensity (Dee et al., 2010). It was reported that PRRSV
could be infectious for 24 h at 37◦ C (or 99◦F) and survive for
6 days at 21◦C (or 70◦F) (Pitkin et al., 2017). Given its airborne
features and survivability, proper treatment of PRRSV aerosols
could effectively reduce the transmission of the disease.
Previous research on the aerosolized PRRSV focused primarily
on virus detection and secondarily on engineering, e.g., control
of flow rate, pressure, mass balance, and uncertainty analyses.
Hermann et al. (2006) optimized a sampling system with
six channels for simultaneous PRRSV aerosol recovery and
detection. Different sampling devices, parameters, and conditions
were compared for optimal airborne virus sampling. Cutler
et al. (2012) built upon this work by establishing a PRRSV
aerosolization and treatment system with four channels (quartz
tubes) for UVC disinfection. Another means of mitigating
PRRSV was reported by La et al. (2019), where air ionization
was applied on viral aerosols. Systems regarding aerosolization,
inactivation, and collection of aerosols were also utilized in
studies of other airborne viruses. Welch et al. (2018) established
an aerosol exposure chamber (one-channel) where influenza
virus was aerosolized, treated by UV, and then sampled by
a biosampler; however, that system did not have engineering
controls or regulation on airflow rate as well as pressure.
A large gap remains in the knowledge needed to develop
effective and practical mitigation technologies for airborne
pathogens. In particular, this research requires controlled systems
under which mitigation technologies can be tested. We were
motivated by the scarcity of research on aerosolized PRRSV and
potential limitations of previous data collected without real-time
monitoring of an aerosolization system. The objectives of this
study were to:
(1) build and test a virus aerosolization system,
(2) provide a method and protocol of engineering control to
regulate pressure and flow rate to ensure uniform aerosol
generation and collection throughout all the experiments,
as preparation for subsequent research on proper treatment
(i.e., UV light) on aerosolized PRRSV,
(3) conduct mass balance calculations and uncertainty analyses
to minimize variation and validate the system, and
(4) conduct PRRSV aerosolization and sampling experiments
to verify the equivalency of the impingers.
This research aimed to provide a more quantitative,
engineering perspective on controlling the process of
aerosolization and collection of viral aerosols to better inform
future research on treating aerosols and reduce uncertainty on
the collected samples.
MATERIALS AND METHODS
Experiment Setup (Obj. 1 and 2)
The system (Figure 1 and Supplementary Figure 1) mainly
consisted of three major sections: (i) aerosolization section,
(ii) treatment section, and (iii) sampling section, following the
direction of the airflow.
The (i) aerosolization section (Supplementary Figure 2)
was responsible for generating PRRSV aerosols that were to
be introduced to the treatment section. It included an air
compressor (built-in with the fume hood), a pressure regulator,
pressure gages, a mass flow controller (MFC) (model No.: GFCS-
010013, Aalborg Instruments and Controls Inc., Orangeburg,
New York, United States), a 24-jet collison nebulizer (formerly
BGI Inc., now CH Technologies, Westwood, NJ, United States)
(Supplementary Figure 3) with the addition of a pressure gage,
and a glass container (12 L, or 3 gal) (Supplementary Figure 4).
The pressure regulator included an air filter to remove dust before
it came to MFC. The glass container has three channels, two of
which were connected with manifolds (1 and 2), and the 3rd one
was closed and considered emergency relief in case the inside
pressure was too high for the system to handle (never used in the
course of experiments).
The (ii) treatment section was designed to be used for
subsequent aerosol treatment experiments (such as UV light,
filtration, microwave). It included manifold 1 (with two pressure
gages mounted on top) and all eight branches with quartz tubes
and plastic connectors (see the construction of manifolds 1 and 2
in Supplementary Figures 5–8).
The (iii) sampling section was where the aerosols were
collected in the sampling media [phosphate-buffered saline
(PBS)]. It consisted of manifold 2 with eight identical branches
connected to eight flowmeters (Catalog No. RMA-21-SSV,
Dwyer Instruments Inc., Michigan City, IN, United States)
(Supplementary Figures 9, 10), eight glass AGI 7541 impingers
(Ace Glass Inc., Vineland, NJ, United States), pressure gages, a
mass flow meter (MFM) (model No.: GFMS-010014, Aalborg
Instruments and Controls Inc., Orangeburg, New York,
United States), and a vacuum pump (VT 4.16 rotary vane
vacuum pump, Becker Pumps Corp., Cuyahoga Falls, OH,
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FIGURE 1 | Experimental setup for generation and collection of airborne PRRSV inside a fume hood. The built-in air compressor in the fume hood was responsible
for pressurizing air flowing into the system, and the right-side pump was vacuuming exhaust air coming out of the system. MFC, mass flow controller; MFM, mass
flow meter.
United States) (Supplementary Figure 11). The AGI 7541
impingers have a designed flow rate of 6 L/min, and they were
tested under experimental conditions where the actual flow rates
were verified by Dwyer flowmeters.
All sections of the systems had sensors for temperature (T) and
relative humidity (RH) (Table 1). Hose clamps reinforced all the
connections between any fitting and plastic tubing to reduce the
risk of leakage. According to the MFC and MFM manufacturer,
the inlet air needed to be below 70% RH (met this requirement
based on measurements) and with a particulate matter (PM) size
of <50 (ensured by the filter in the pressure regulator). Both
conditions were met in all trials.
Compressed air supplied by the fume hood passed through
an MFC and then to a 24-jet collison nebulizer to pressurize
the PRRSV inoculum and generate the aerosols. The nebulizer
was prefilled with 60 ml of PRRSV inoculum, with 0.2% (v/v)
antifoam A emulsion (Sigma-Aldrich Corp., St. Louis, MO,
United States) known to reduce foaming and with no effect either
on laboratory-cultured cells or PRRSV itself (Hermann et al.,
2006). The nebulizer aerosolized 33∼37 ml of PRRSV inoculum
in each (∼45-min) experiment.
Viral aerosols were then directed to the glass container and
then into manifold 1, where they were distributed into eight
branches (quartz tubes). The rear (right side) end of each quartz
tube was connected to an impinger where the aerosols were
captured. Each impinger was prefilled with 15 ml of PBS and 0.2%
(v/v) antifoam A emulsion. Downstream of each impinger was a
flow meter with an adjustable needle valve to ensure that all eight
tubes had the same flow rates.
A vacuum pump (outside of the fume hood) forced constant
airflow through manifold 2, confirmed by an MFM. During the
experiment, the vacuum pump was turned on first, immediately
followed by the compressed air valve. Once the reading of the
sensors (MFC, pressure gage, etc.) became stable (within a few
minutes), the timer for each experiment was started.
A Theoretical Model for the Mass
Balance of Airflow in Virus
Aerosolization, Treatment, and
Impingement System (Obj. 3)
The theoretical model assumes steady-state conservation of mass
and energy during data collection. The purpose of this section
is to present the % difference in the mass flow rate of dry
air between inlet and outlet in order to detect significant air
leakage in the system, to optimize the flow rate, to understand
how an aerosolization system would work, and estimate the
concentration of PRRSV in the sampling liquid.
Overall Mass Balance of Airflow Through the System
A mass balance for dry air is established for the aerosolization and
impingement system,
ṁa1 = ṁa3 (1)
where ṁa1 is the mass flow rate of dry inlet air (kga/s) and
ṁa3 is the mass flow rate of dry outlet air (kga/s).
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TABLE 1 | Summary of the monitoring sensors in the system and their specifications.
Parameters Location Sensor type Label
Temperature and relative humidity Ambient air Omega smart temperature and humidity probe T1, RH1
Temperature and relative humidity Manifold 1 Omega smart temperature and humidity probe T2, RH2
Temperature and relative humidity Manifold 2 Omega smart temperature and humidity probe T3, RH3
Pressure Nebulizer Analog pressure gage P1
Pressure Manifold 1 Omega digital pressure gage P2
Pressure Manifold 2 Omega digital pressure gage P3
Airflow System inlet Aalborg mass flow controller (MFC) Q1
Airflow After impingers Dwyer flowmeter Qst
Airflow System outlet Aalborg mass flow meter (MFM) Q3
FIGURE 2 | Mass balance of water vapor in the virus nebulizer. The inlet water
vapor content plus the water vapor content generated in the nebulizer (from
the virus inoculum) is equal to the water vapor content exiting the nebulizer.
Mass flow rate is the product of the density times volumetric
flow rate. Therefore, density and volumetric flow rates need to be
determined.
ṁa1 = ρ1Q1 (2)
ṁa3 = ρ3Q3 (3)
where ρ1 is the inlet air density (kga/m
3),
ρ3 is the outlet air density (kga/m
3),
Q1 is the actual measured flow rate (m3/s) passing MFC,
and Q3 is the actual measured flow rate (m3/s) passing MFM.
A general equation to correct the measured flow rate reading
on the rotameters according to the pressure enacted on the
flowmeter was used (Eq. 8).
Mass Balance of Water Vapor Through the Virus
Nebulizer
The mass balance of moisture through the nebulizer (Figure 2)
is:
ṁa1w1 + ṁw, nebu = ṁa1w2 (4)
where ṁw,nebu is the change of water vapor content (kgw/s)
caused by the nebulizer,
w1 is the humidity ratio (kgw/kga) of airflow before nebulizer
(Figure 2), and
w2 is the humidity ratio (kgw/kga) of airflow after nebulizer
(Figure 2)
Resulting in the theoretical water vapor content gained during
the nebulization process,
ṁw,nebu = ṁa1(w2 − w1) (5)
An online psychrometric calculator program (Marcks, 2006)
was used to calculate the humidity ratio (w) and air density
(ρ). Results are within the scope of ANSI/ASHRAE 41.6-1994
(ASHRAE, 2006). The input needed to yield these two variables
(w, ρ) were the measured relative humidity (RH1, RH2, or RH3),
standard temperature (defined as 21.1◦C, based on instruction
manuals from Aalborg and Dwyer), and standard pressure
(defined as 14.7 psia, based on instruction manuals from
Aalborg and Dwyer).
The air density (ρ) in Eqs. (2) and (3) is the air density at
standard conditions (21.1◦C and 14.7 psia), 1.19 kga/m
3. The
variation of RH on ρ under standard conditions is negligible
(<1%), and thus the change of ρ was ignored.
Mass Balance of Water Vapor Through the Impingers
The change of water vapor content across the eight impingers




ṁw, impg = ṁa3w3 (6)
where ṁw,impg is the change of water vapor content (kgw/s)
caused by each of the impingers.
After rearranging the terms,∑8
n=1
ṁw, impg = ṁa3w3 − ṁa1w2 (7)
Mass Balance of Water Vapor Through the
Flowmeters (Downstream From Impingers)
Airflow through each (n = 8) of the Dwyer flowmeters, corrected
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FIGURE 3 | Mass balance of water vapor in the impinger to trap aerosolized
virus into sampling liquid. A visual demonstration supplements Eq. (7); the
water vapor content arriving in the impinger plus the water vapor content
absorbed from the sampling liquid is equal to the water vapor content exiting
the impinger.
where Qst is the standard flow corrected for pressure and
temperature,
Qob is the observed flowmeter reading (L/min),
Pa is the measured absolute pressure: atmospheric pressure
(14.7 psi)± gage pressure (psi),
Pst is the standard pressure (14.7 psi),
Ta is the measured temperature (Rankine scale, ◦R),
and Tst is the standard temperature (530◦R).
Note that in Eq. (8), all the units under the square root sign are
canceled by each other, so the only term that determines the units
of this equation is Qob. This is significant because Eq. (8) is also
used in the mass balance and uncertainty analyses.
















In the end, combining Eqs. (1), (5), and (7) results in the water
vapor balance of each component in the system,
ṁa1w1 + ṁw,nebu +
∑8
n=1
ṁw, impg = ṁa3w3 (11)
ṁa1w1 + ṁa1(w2 − w1)+ (ṁa3w3 − ṁa1w2) = ṁa3w3 (12)
where ṁa1w1 is the mass flow rate of dry air coming into the
system multiplied by the humidity ratio of the air coming into the
system and ṁa3w3 is the mass flow rate of dry air coming out of
the impingers multiplied by the humidity ratio of the air coming
out of the impingers.
Stabilization of Aerosols: Calculation of Residence
Time in the Glass Container
The aerosol residence time refers to the time that an aerosol
particle stays in the glass container before it is directed to
manifold 1. Assuming that the glass container is a “continuous
stirred flow reactor” system (Cutler et al., 2013), the mass balance
for the concentration of the target substance (e.g., aerosolized




= QCin − QC + ∅ (13)
where V is the volume of the glass container (L),
C is the concentration of the target aerosol in the container,
Cin is the concentration of the target aerosol entering the
container,
Q is the volumetric flow rate (L/min),
and ∅ is the addition or subtraction of matters in the container
in case of a reaction. In this model, it is assumed that there is
no reaction in the container, so ∅ = 0.
t is the experiment or operation time (s)
Equation (13) can be rearranged to show the change of the
aerosol concentration in the container,
C = Cin(1− e−t
Q
V ) (14)







= 0.24 min = 14 s (15)
Based on Table 2 and Figure 4, the glass container was assumed
to be at a steady state and contains 99% of the PRRSV aerosols,




1 τ (14 s) 1− e−1 = 63%
2 τ (28 s) 1− e−2 = 86%
3 τ (42 s) 1− e−3 = 95%
4 τ (56 s) 1− e−4 = 98%
5 τ (70 s) 1− e−5 = 99%
The aerosol concentration with respect to the number of residence times in the
glass container.
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Residence Time (1 unit = 14 s)
Theoretical PRRSV aerosol concentration in the 
glass container (12 L)
FIGURE 4 | Steady-state conditions for the aerosolized virus. Theoretical PRRSV aerosol concentration in the glass container (12 L) with respect to the operation
time (expressed in terms of the aerosol residence time within the glass container).
sufficient for stabilization purposes after 5 τ (70 s) of system
operation. Therefore, after 70 s, the valves were turned on, and
aerosols were directed into manifold 1.
Uncertainty Analysis in the Mass
Balance Model (Obj. 3)
First-order error analysis (FOEA), also known as the root sum of
squares (RSS) method, was used to present the overall magnitude
of measurement uncertainties. In the analysis below, θ refers
to the sensitivity of the results, which was calculated by taking
the partial derivative regarding each variable, while U refers to
the individual measurement uncertainty (composed of both bias
errors and precision errors). Adopted from Dettinger and Wilson
(1981) and Zhang and Yu (2004), the overall uncertainty equation





where Utot is the total uncertainty of the equipment of study
(e.g., a flowmeter),
θn is the sensitivity of the nth variable, which is calculated
by taking the partial derivative of the equation (e.g., mass
balance) with regard to variable n,
Un is the measurement uncertainty of the nth variable in the
mass balance equation. This value is usually determined by the
manufacturers of the measurement device.
Uncertainty Analysis of Mass Flow in the System Inlet
and Outlet
For the overall system inlet and outlet, the mass flow rates are
described in Eqs. (2) and (3). Since ρ1 and ρ3 were constants,
the uncertainty was determined from Q1 and Q3, which were
measured by MFM and MFC, respectively. The uncertainty
of either one is 1% of full scale reading, according to the
manufacturers’ manual.
For MFC or MFM, the sensitivity and uncertainty of ṁa1 with




= ρ1 = 1.19 kga/m
3 (17)
UQ1 = accuracy(%) × FMFC (18)
where FMFC is the full scale of the MFC (or MFM)
(UQ1 = 1%× 48 L/min = ± 0.48 L/min = 8× 10
−6 m3/s)






The total uncertainty of MFM (for outlet) is the same as MFC
because ρ1 = ρ3 = 1.19 kga/m
3 (based on the assumption made
in section “Mass Balance of Water Vapor Through the Virus
Nebulizer”), UQ1 = UQ3 = 4.8× 10−4 m3/s; therefore, the
calculation is the same as above. In this case, the uncertainty for
mass flow inlet and outlet is constant, which does not change
due to environmental conditions. Based on the known values
and taking them into Eq. (19), results in Uṁa1 = Uṁa3 = 9.52×
10−6 kga/s.
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Uncertainty Analysis of Mass Flow Through Each
Flowmeter (Quartz Tube)
The flowrate of each Dwyer flowmeter is expressed as follows
















For each of the variables in Eq. (21), its θn (the sensitivity) is
calculated by taking the partial derivative of Eq. (21) with respect









UQob = accuracy(%) × FSf (23)
where FSf is the full scale of the flowmeter (RMA-21-SSV),








(36.0544P3 + 530)(T3 + 460)
(24)
UP3 = accuracy(%)× FSp (25)
where FSp is the full scale of the pressure gage, and thus



















In addition, UT3 = ± 0.2◦C of reading, Uρ2 = ±
2.25% of reading.
Thus, the total uncertainty for ṁa2, the mass flow through each














Example Calculation of the Uncertainty
Analysis (Obj. 3)
The summary of measured values for the mass balance model and
uncertainty analysis are shown in Table 3.
Taking the values from Table 3 above into Eqs. (4) and
(5) results in ṁa1 9.50× 10−4 kga/s, ṁa3 = 9.72× 10
−4 kga/s.
Therefore, the percentage difference of mass flow between the
entire system inlet and outlet was, ṁa3−ṁa1ṁa1 × 100% = 2.32%.
This indicates relatively low variability and a good mass balance
closure. This illustrates sufficient quality control in the assembled
and tested virus aerosolization system.
For each quartz connected to a Dwyer flowmeter, based on
Eq. (28), the uncertainty is Uṁa2 = 7.72× 10−6 kga/s. According
to Eq. (21), ṁa2 = 1.18× 10−4 ± 7.72× 10−6 kga/s, or 1.18×
10−4 kga/s± 6.54%. Thus, the uncertainty is minimal, and it
does not affect the accuracy of engineering control.
Confirmation of Uniform Airflow
Distribution Among Treatments (Obj. 2
and 4)
Rhodamine B (Sigma-Aldrich Corp., St. Louis, MO,
United States), a fluorescent physical tracer (excitation
wavelength = 544 nm, emission wavelength = 576 nm) that
is not harmful to mammalian cells and viruses (Hermann
et al., 2006), was used to confirm the uniformity of the airflow
across the eight tubes before the experiments on PRRSV began.
Rhodamine B was dissolved in PBS to achieve a concentration
of 2 ppm and 60 ml, placed into a 24-jet collison nebulizer
and aerosolized in each experiment. Before each experiment,
the system was tested with PBS (no rhodamine B added),
and the Dwyer flowmeters were adjusted to ensure that
their readings were the same. After the 10-min experiment,
2 ml of liquid from each impinger was transferred into
polystyrene cuvettes (Model No. 2405, Stockwell Scientific,
Scottsdale, AZ, United States) and warmed up for 10 min
in the dark so that they rose to room temperature. The
fluorescent intensity was measured by a Modulus Fluorometer
(Model 9200-000, Turner Biosystems Inc., Sunnyvale, CA,
United States) which was equipped with a green optical kit
(Model 9200-042, Turner BioSystems Inc., Sunnyvale, CA,
United States). Each sample was distributed into three aliquots
(2 ml each), with three measurements each, and the average
value was recorded.
PRRSV Propagation, Isolation, and Virus
Titer Determination (Obj. 4)
The PRRSV used in this experiment (MN-184, PRRSV-
2 Lineage 1) was provided by the Veterinary Diagnostic
Laboratory (College of Veterinary Medicine, Iowa State
University). The virus was propagated in the MARC-145
cell line, a clone of the African monkey kidney cell line
MA-104 (Kim et al., 1993). MARC-145 cells were cultured
in the RPMI-1640 medium supplemented with 10% fetal
bovine serum, 2 mM L-glutamine, 0.05 mg/ml gentamicin,
100 unit/ml penicillin, 100 µg/ml streptomycin, and 0.25 µg/ml
amphotericin. Large-scale virus propagation was conducted
in five-layer flasks (Thermo Fisher Scientific, Rochester,
NY, United States). Briefly, when cells reached 80–90%
confluence, stock PRRSV was added. The estimated number
of cells at that range of confluency was 18.6–21.0 × 106
cells/layer (Thermo Fisher Scientific – US, 2021). Flasks were
observed daily for cytopathic effect (CPE). When the CPE
was abundant (5–7 days), flasks underwent two freeze-thaw
cycles, followed by centrifugation at 4,200×g for 10 min to
harvest the supernatant. Approximately 3 L of virus inoculum
was harvested with a geometric mean virus titer of 105.56
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TABLE 3 | Sample data collection for all variables needed for mass balance and uncertainty analysis.
Location Variable Reading Uncertainty Measurement device
Inlet/ambient T1, RH1 21.0◦C, 15.9% ±0.3◦C of reading, ±2% of reading Omega smart temperature and humidity probe
System inlet Q1 47.9 L/min ±1% FS Aalborg mass flow controller
Nebulizer P1 21.5 psi ±0.25% FS Pressure gage
Manifold 1 P2 0 psi 2% FS for the middle half Pressure gage
Manifold 1 T2, RH2 20.2◦C, 84.6% ±0.3◦C of reading, ±2% of reading Omega smart temperature and humidity probe
Manifold 2 P3 −4.85 psi 2% FS for the middle half Vacuum gage
Manifold 2 T3, RH3 20.8◦C, 16.7% ±0.3◦C of reading, ±2% of reading Omega smart temperature and humidity probe
Postimpinger Qob 7.25 L/min* ±3% of reading Dwyer flowmeter
System outlet Q3 49.0 L/min ±1% FS Aalborg mass flow meter
Ice buckets** – 0∼2◦C N/A Thermocouples
*The actual flowrate (Qst) was derived from the observed flow rate (Qob) using Eq. (8). In this case,Qst was 5.9 L/min. **Ice bath (container with water and ice mixture)
was provided for nebulizer and impingers so that their temperature can be maintained around 0◦C to extend the survivability of PRRSV. Tn, temperature (◦C); RHn, relative
humidity (%); Pn, pressure (Pa); Qn, flow rate (L/min); FS, full scale.
TCID50/ml. The inoculum was thoroughly mixed to ensure
homogeneity, distributed into 30 ml aliquots and stored
at−80◦C.
For determination of TCID50 in research samples, impinger
fluid was transferred to a biosafety cabinet in a BSL-2 laboratory,
and tenfold serial dilutions were performed, with eight replicates
for each sample. Each well (in 96-well plates) was prefilled
with 270 µl of RPMI-1640 medium, and then the sample was
added to the first row of the plates; the solution was mixed,
and then 30 µl of liquid transferred sequentially from one
row to another. Thus, the dilution for each row ranged from
100, 10−1, . . ., to 10−7, respectively. We considered the 100
dilutions to improve method detection limits for the benefit of the
subsequent experiments on PPRSV survival after UV treatment.
Thereafter, 100 µl from each well was inoculated into 80∼90%
subconfluent MARC-145 cells grown in 96-well plates. The plates
were incubated at 37◦C in a humidified 5% CO2 incubator. CPE
development was checked under a microscope daily, and infected
wells were marked as positive until no more additional wells
were identified as infected (5–7 days). To confirm the presence
of PRRSV, the plates were fixed (80% acetone for 10 min),
dried, and stained with a PRRSV nucleocapsid protein-specific
monoclonal antibody (SDOW17-F) conjugated to fluorescent
isothiocyanate (Rural Technologies, Inc., Brookings, SD) for
1 h at 37◦C. The antibody conjugate was decanted, and the
cell plates were washed with PBS (1× pH 7.4) three times,
5 min each time. Plates were read under an Olympus IX71
fluorescent microscope (Olympus America Inc., Center Valley,
PA, United States). The Spearman-Karber method (Karber, 1931;
Lei et al., 2020) was used to calculate the virus titers, which
were based on the number of wells showing positive PRRSV-
specific fluorescence at specific dilution and the results expressed
as TCID50 per milliliter of the impinger fluid (Cutler et al., 2012;
Yim-Im et al., 2021).
Statistical Analysis
The statistical analysis was conducted using JMP Pro (Version 15,
SAS Institute Inc., Cary, NC, United States). One-way ANOVA
and Tukey’s test was used to determine statistical significance.
p-values regarding the virus titer were calculated and compared
between each combination of two trials (out of the total of
three trials). If a p-value was <0.05, the results were considered
significantly different.
RESULTS
Verification of Engineering Control on
Airflow Rate in the System (Obj. 3)
During each experiment, environmental data such as
temperature, pressure, and flow rate were measured and
recorded. The results were summarized in Table 4. Table 4
summarized the average values (with± standard deviation) of all
of the environmental data of the (n = 3) three trials with PRRSV.
The purpose of Table 4 is to show the level of engineering
control and environmental conditions that the system had,
and the variation of the data was indeed minimal. The inlet
airflow rate was controlled and measured by the MFC. The inlet
air pressure and pressure in the nebulizer were maintained at
∼20 psi (1.4 atm).
Table 5 presents TCID50 estimates of PRRSV concentration
in the nebulizer and impingers. The comparison showed that a
fraction of the PRRSV present in the nebulizer was subsequently
recovered in the impingers. This reflects the inactivation of
the infectious virus during the process of nebulization, in the
aerosolized state, by the process of impingement, and during
sample handling, as well as the inefficiency of impingement itself.
Rhodamine B was used as a tracer (positive control) to
account for variation among treatments (Table 6). All trials had
relative standard deviations (RSD) <12%. These three trials were
independent of the trials mentioned in Table 3, and the only
purpose was to evaluate the system integrity before aerosolizing
PRRSV. The RSD below 12% for the Rhodamine dye is acceptable
in the context of virology research. Inherent variability is assumed
for work on biological systems that is generally higher than in
engineering fields.
Verification of the Uniformity of Airborne
PRRSV Titer Across the Treatments
(Obj. 3)
The virus titer of the impinger fluid collected from each
trial was expressed in the form of log10 normalization
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TABLE 4 | Environmental data for all experimental trials on aerosolization and collection of PRRSV.
Environmental parameters (mean ± St. Dev.)
Engineering-controlled parameters Inlet air flow rate (L/min), Q1 47.9 ± 0.4
Inlet air pressure (psi), P1 24.6 ± 0.6
The air pressure in the nebulizer (psi), P2 20.7 ± 0.6
The pressure at Manifold 2 (psi), P3 −4.9 ± 0.4
Outlet airflow rate (L/min), Q3 49.1 ± 0.1
Total airflow (L) 2,157.0 ± 16.6
Average airflow rate per treatment (L/min) 5.8 ± 0.1
Total airflow per treatment (L) 262.5 ± 4.5
Monitored parameters (uncontrolled) Ambient air: temperature (◦C) and RH (%),T1, RH1 21.1 ± 0.7 41.6% ± 6.4%
Manifold 1 temperature (◦C) and RH (%),T2, RH2 20.1 ± 0.5 80.0% ± 2.2%
Manifold 2 temperature (◦C) and RH (%), T3, RH3 20.6 ± 0.2 36.3% ± 3.8%
The system was designed to control and minimize variations of physical parameters. St. Dev., standard deviation.
TABLE 5 | Measured and estimated TCID50 values from the medium in the nebulizer and in impingers.












Description 35 ml of virus inoculum
aerosolized for 45 min per
experiment
15 ml of medium per impinger
(8× in total per experiment)
–
*Estimated as the geometric mean for nebulizer and impingers. **The geometric mean of PRRSV titer in the impinger fluid from the (n = 3) trials.
TABLE 6 | Pre-PRRSV experimental verification of air flowrate in each treatment (quartz tubes 1–8) with rhodamine B.













Treatment 1 5.11 × 103 −1.3% 5.41 × 103 14.7% 4.09 × 103 0.7%
Treatment 2 4.73 × 103 −8.6% 4.63 × 103 −2.0% 4.91 × 103 20.9%
Treatment 3 4.56 × 103 −12.0% 4.01 × 103 −15.1% 3.56 × 103 −12.5%
Treatment 4 5.70 × 103 10.1% 4.84 × 103 2.6% 3.75 × 103 −7.8%
Treatment 5 5.28 × 103 2.0% 5.02 × 103 6.3% 3.48 × 103 −14.4%
Treatment 6 5.08 × 103 −1.9% 4.50 × 103 −4.7% 4.17 × 103 2.6%
Treatment 7 5.32 × 103 2.8% 4.86 × 103 3.0% 4.53 × 103 11.4%
Treatment 8 5.64 × 103 8.9% 4.49 × 103 −4.9% 4.03 × 103 −0.9%
Mean 5.18 × 103 – 4.06 × 103 – 4.06 × 103 –
St. Dev. 3.99 × 102 – 4.54 × 102 – 4.54 × 102 –
RSD 7.7% – 8.3% – 11.2% –
FSU, fluorescent standard unit; St. Dev., standard deviation; RSD, relative standard deviation. **Percentage difference (%): deviated from the average value of the eight
samples (of treatments).
(Table 7). Mean, geometric mean, and standard
deviations were calculated to evaluate the variability
within and between the experimental trials. Data in
Table 7 was used to estimate the total geometric mean
of PRRSV titer in impingers (i.e., “3.798” reported in
Table 5).
Statistical analysis on virus titer (both numerical and log10-
based values) was summarized in Table 8.
Figure 5 shows the morphological changes of MARC-145
cells under an optical microscope on 3 days postinoculation
of the cells with the sample. In Figure 5A where cells were
inoculated with the control impinge fluid, i.e., virus-negative
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TABLE 7 | Experimental verification of uniformity of the PRRSV titer
(log10(TCID50)/ml) in the sampling fluid among identical eight treatments.
PRRSV titer(log10(TCID50)/ml)
Sample source Trial 1 Trial 2 Trial 3
Treatment 1 3.88 3.88 4.00
Treatment 2 3.88 4.13 3.38
Treatment 3 4.13 4.00 3.25
Treatment 4 3.88 3.63 3.63
Treatment 5 3.75 4.13 4.13
Treatment 6 3.88 4.00 3.13
Treatment 7 3.75 3.88 3.63
Treatment 8 3.88 3.63 3.75
Mean ± St. Dev. 3.88 ± 0.11 3.91 ± 0.18 3.61 ± 0.33
Geo mean ± St. Dev. 3.88 ± 0.11 3.90 ± 0.19 3.59 ± 0.33
RSD 2.8% 4.7% 9.1%
Least square mean 3.88 3.91 3.61
SD error 0.085
Lower 95% 3.70 3.73 3.44
Upper 95% 4.06 4.09 3.79
St. Dev., standard deviation; Geo Mean, geometric mean; RSD, relative standard
deviation (based on mean and st. dev.); SD error, standard error.






Trial 2 vs. trial 3 0.1479 0.0560
Trial 1 vs. trial 3 0.3572 0.0934
Trial 2 vs. trial 1 0.8458 0.9638
p-values were shown for the three comparisons.
PBS, no CPE was observed. In contrast, in Figure 5B where
cells were inoculated with the collected PRRSV impinger fluid,
CPE characterized by enlargement and clumping of cells was
observed. The cell plates were then placed back into the incubator
for continuous CPE development until 5–7 days postinoculation.
At that time, cells were fixed and stained with FITC-conjugated
PRRSV-specific antibody to confirm the infection status of the
cells. Examples of immunofluorescence staining are shown in
Figure 6. No immunofluorescence staining was observed in the
cells inoculated with the control impinger fluid (Figure 6A).
In contrast, in the cells inoculated with the collected PRRSV
impinger fluid, positive staining by PRRSV-specific antibody
conjugate was clearly observed (Figure 6B).
DISCUSSION
Sources of Variation
Sources of variation in the data included engineering
factors, e.g., sensor measurements (temperature, relative
humidity, flow rate), physical tracer (Rhodamine B), and
biological factors, e.g., biologically based estimates of virus
titer. In the engineering aspect, an uncertainty analysis
was conducted with respect to sensor measurements, and
the goal was to control and minimize the uncertainty.
Ultimately, low variation in the engineering controls minimizes
the risks of unacceptable biological variability (which is
inherently higher).
Reproducibility
The Rhodamine B fluorometric data supported the conclusion
that the airflow was uniform among the eight treatments
(tubes) (Table 6), i.e., the RSD among all eight treatments
(tubes) was <12%, given all the engineering controls mentioned
in the previous sections. However, the absolute values of
the fluorescence intensity varied among different trials and
cannot be used as verification of flow rate because the
variation of flow rate (controlled and verified by MFC,
MFM, Dwyer flowmeters) was almost negligible between any
two trials (section “Example Calculation of the Uncertainty
Analysis (Obj. 3)”).
The PRRSV TCID50 estimation of infectious virus is a complex
quantal assay that requires (a) the propagation of cell cultures, (b)
inoculation of cells with the virus, and (c) visual assessment of the
infection of cells by the virus. Despite the biological complexities,
TCID50 estimates were relatively consistent within and between
trials (Table 7).
The system provided acceptable control of flow rate, pressure,
and other physical factors while minimizing the potential effect
on the microinfectivity assay. The follow-up research on the
inactivation of aerosolized PRRSV using UV-C and UV-A
irradiation is described by Li et al. (2021). The same type of
studies (aerosolization and recovery) and mitigation could be
done using other important airborne pathogens.
Limitations
The system can only control with a flow rate that is <50 L/min;
more specifically, the inlet air flow rate was controlled to
be around 48 ± 0.5 L/min. For a higher flow rate, this
system would not be practical to handle and would require a
redesign, testing, and commissioning similar to the approach
presented herein.
The selection of impingers was based on the flow rate,
reliability, and cost. Multiple models of impingers were
considered, such as SKC BioSampler, AGI 7541, AGI 7542 (also
known as AGI 30), etc. Eventually, AGI 7541 was chosen because
its designed flow rate is 6 L/min, only half of the designed
flow rate of SKC BioSampler or AGI 7542. The lower flow rate
impingers allowed for greater flexibility in evaluating UV light’s
effect on infectious PRRSV in the subsequent research (Koziel
et al., 2020; Li et al., 2021). On the one hand, a lower flow
rate reduces the efficiency of sampling aerosols. However, on the
other hand, a lower flow rate allows more treatment time for
the aerosols that are suspended in the air before being captured
by the impingers. Thus, the subsequent study (i.e., testing the
UV light to inactivate the PRRSV aerosol) benefitted from
a wider range of treatment times available (Koziel et al., 2020;
Li et al., 2021).
The majority cost of the system was attributed to the
sensors, especially the Aalborg MFC and MFM. The
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FIGURE 5 | Views of MARC-145 cells at 3 days postinoculation with control impinger fluid (A) and with the collected PRRSV impinger fluid (B). Magnification, ×160.
FIGURE 6 | Immunofluorescence staining of cells inoculated with control impinger fluid (A) or PRRSV impinger fluid (B) with PRRSV-specific antibody conjugated to
FITC. Pictures were taken on 6 days postinoculation when the MARC-145 cell plates were fixed using 80% acetone and stained by SDOW-17 PRRSV FITC
conjugate. Magnification, ×160.
Omega Smart Probes were the second most expensive,
while the electronic pressure gages were the third. Some
cost savings could be realized by using less expensive
sensors (as described in Supplementary Material 1).
However, we highly recommend conducting the error
propagation and uncertainty analyses as part of the
decision-making process.
Overall, the presented system construction and protocol
for aerosolization and sampling of PRRSV could be
applicable to the aerosolization of other viruses. This
experiment could be helpful for future research on virus
aerosolization, treatment, and sampling in both human
and animal health.
CONCLUSION
A system for virus aerosolization and protocol for engineering
control to regulate pressure and flow rate to ensure uniform
aerosol generation and collection was described. The system
for virus aerosolization was built and tested (Obj. 1). The
uniform airflow distribution was confirmed by the physical
tracer (<12% RSD) for all the treatments and sound engineering
control of flow rates (Obj. 2). Theoretical uncertainty analysis
and mass balance calculation to identify potential variations
and reduce them were conducted to prove that a <3% loss
of air mass flow rate between the inlet and outlet (Obj.
3). The results showed that the PRRSV titers collected from
the impingers were not statistically different, indicating that
the variations were acceptable. This indicated the readiness
of the system for research on virus aerosolization and
treatment (e.g., by ultraviolet light). The TCID50 values of
the collected impinger fluids showed no statistical difference
between any two of the three trials (p-value = 0.148, 0.357,
0.846) (Obj. 4). The presented virus aerosolization system
and protocol are also potentially useful for research of
other types of airborne pathogens and their mitigation on a
laboratory scale.
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